Author:
Kay Jonathan,Feagan Brian G.,Guirguis Micheal S.,Keystone Edward C.,Klein Agnes V.,Lubiniecki Anthony S.,Mould Diane R.,Nyarko Kwasi A.,Ridgway Anthony A.G.,Trudeau Maureen E.,Wang Jian
Subject
Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Reference44 articles.
1. Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3–4, 2011, Freiburg, Germany;Reichert;MAbs,2011
2. WHO/KFDA joint workshop on implementing WHO guidelines on evaluating similar biotherapeutic products, Seoul, Republic of Korea 24–26 August, 2010;Wadhwa;Biologicals,2011
3. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues. EMEA/CHMP/BWP/49348/2005;Committee for Medicinal Products for Human Use, European Medicines Agency,2006
4. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues. EMEA/CHMP/BMWP/42832/2005;Committee for Medicinal Products for Human Use, European Medicines Agency,2006
5. Guidelines on evaluation of similar biotherapeutic products (SBP);World Health Organization,2009
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献